Skip to Main Content

News

Results: 28 Articles found.
  • Cundiff__5b1_5d2018

    State of the Society

    Oct 17, 2019 10:32 AM

    As I complete my Presidency of AUGS, I would like to bring to you a summary of the State of the Society. 2019 has been a busy year with many developments that impact our specialty but are outside of our direct control.

    Read More
  • Cundiff__5b1_5d2018

    AUGS Creates a Patient Advisory Group

    Aug 02, 2019 01:18 PM

    The American Urogynecologic Society was founded to serve the needs of medical professionals serving women who suffer from pelvic floor disorders. Patients have always been at the center of AUGS' mission, but have not been directly involved in the conversation.

    Read More
  • Cundiff__5b1_5d2018

    AUGS Code of Conduct for Expert Witnesses

    Jun 06, 2019 10:50 AM

    In recent months many members of AUGS have been frustrated by misinformation related to surgical technologies and materials that creates fear and anxiety in our patients. Media reports are often superficial and polarizing. For example, coverage of FDA decisions often fails to distinguish between transvaginal mesh for prolapse, and other forms of pelvic mesh (such as slings or sacrocolpopexy mesh). Even more alarming are those who employ misinformation and fear to seek personal profit.

    Read More
  • Cundiff__5b1_5d2018

    Call for Volunteers and Board Nominations

    May 22, 2019 10:57 AM

    Have you ever thought about volunteering to help AUGS? It is that time of year for our annual Call for Volunteers and Board Nominations, so maybe you should.

    Read More
  • Cundiff__5b1_5d2018

    Update on FDA Announcement on Transvaginal Mesh for Prolapse

    I write today to update my last Presidential Message from April 18, 2019 on the April 16th FDA Announcement ordering both manufacturers of the three surgical mesh products for transvaginal repair of prolapse to stop selling and distributing their products in the U.S.

    Read More
  • Cundiff__5b1_5d2018

    FDA Announcement on Transvaginal Mesh for Prolapse

    Apr 18, 2019 10:40 AM

    AUGS received notice from the FDA on Tuesday, April 16, of the simultaneous public notice, “FDA Takes Action to Protect Women’s Health; Orders Manufacturers of Surgical Mesh Intended for Transvaginal Repair of Pelvic Organ Prolapse to Stop Selling All Devices”. The notice orders all manufacturers of surgical mesh products for transvaginal repair of prolapse to stop selling and distributing their products in the U.S. immediately.

    Read More
  • Cundiff__5b1_5d2018

    AUGS to Testify at FDA Advisory Committee Meeting

    On February 12, 2019, the FDA plans to convene an Advisory Committee Meeting to share the available evidence and seek expert opinion on the evaluation of the benefits and risks of trans-vaginal mesh devices for anterior pelvic organ prolapse. This will provide an opportunity for the FDA to hear directly from the public, including patients, about their experiences, and consider additional regulatory actions.

    Read More
  • Cundiff__5b1_5d2018

    President’s Perspective: Statement on Gender Identification

    Oct 31, 2018 12:49 PM

    The U.S. Administration recently notified the media that they are considering the adoption of a narrow definition of gender. The new definition limits gender to male or female, based entirely on an assessment of genitalia at birth.

    Read More
  • Rardin_Charles_2018

    President’s Perspective: Meeting Code of Conduct for AUGS Members

    Sep 11, 2018 01:00 AM

    PFD Week is just around the corner, and Chicago in the early autumn is beckoning! The Program Committee has put together an outstanding lineup of all of the science, updates, addresses, and networking that you have come to expect from our annual meeting. Bring your energy, curiosity, enthusiasm, and an open mind to this exchange of expertise and ideas. Bring your concerns and your solutions to the many AUGS Volunteer meetings and activities that go on around the meeting.

    Read More
  • Rardin_Charles_2018

    Energy-Based Devices and Vaginal Rejuvenation

    Aug 08, 2018 04:16 PM

    As you may already know, the FDA released a Safety Communication on July 30 which provided a public warning regarding the use of “Energy-Based Devices to Perform Vaginal 'Rejuvenation' or Vaginal Cosmetic Procedures.” It was very clear in addressing this warning to patients considering undergoing the treatments, and to health care providers who offer them.

    Read More
Results: 28 Articles found.
 
Close